ERIC DEES: Open Payments
NPI 1336658657 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 32 payments from 7 companies in 2025. Trend: 2023 $775 · 2024 $642 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 14 | $303 |
| Braeburn Inc. | 8 | $157 |
| Alkermes, Inc. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
Products named: SUBLOCADE, BRIXADI, VIVITROL, Auvelity, CAPLYTA, ABILIFY MAINTENA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across MT — which companies pay providers there.
